Trials / Active Not Recruiting
Active Not RecruitingNCT02954094
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Target PharmaSolutions, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Conditions
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2016-11-03
- Last updated
- 2026-04-17
Locations
71 sites across 5 countries: United States, France, Germany, Italy, Spain
Source: ClinicalTrials.gov record NCT02954094. Inclusion in this directory is not an endorsement.